HIGHLIGHTS
- who: RNAi therapeutics and collaborators from the Department of Bioengineering, Clemson University, Clemson, SC, USA have published the research work: Mechanisms of Drug Resistance in Ovarian Cancer and Simple Summary: When tumors become resistant to chemotherapeutics alternative treatment strategies must be explored, in the Journal: Cancers 2022, 14, 6246. of /2022/
- what: In this review, the authors examine an array of proteins that have been linked to chemoresistance in ovarian cancer, particularly proteins associated with drug efflux, inhibition of apoptosis, DNA damage and repair, and cancer stem_cells.
- how: Using a precision medicine approach . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.